These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18346788)

  • 1. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide.
    Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Hou S; Guo Y; Ding J
    Mol Immunol; 2008 May; 45(10):2861-8. PubMed ID: 18346788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of novel murine anti-CD20 monoclonal antibodies and their comparison to 2B8 and c2B8 (rituximab).
    Nishida M; Usuda S; Okabe M; Miyakoda H; Komatsu M; Hanaoka H; Teshigawara K; Niwa O
    Int J Oncol; 2007 Jul; 31(1):29-40. PubMed ID: 17549402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of the B-cell marker CD20.
    Ernst JA; Li H; Kim HS; Nakamura GR; Yansura DG; Vandlen RL
    Biochemistry; 2005 Nov; 44(46):15150-8. PubMed ID: 16285718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops.
    Krauss N; Wessner H; Welfle K; Welfle H; Scholz C; Seifert M; Zubow K; Aÿ J; Hahn M; Scheerer P; Skerra A; Höhne W
    Proteins; 2008 Nov; 73(3):552-65. PubMed ID: 18473392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for recognition of CD20 by therapeutic antibody Rituximab.
    Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Huo S; Guo Y; Ding J
    J Biol Chem; 2007 May; 282(20):15073-80. PubMed ID: 17395584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apoptosis of human B cell lymphoma Raji cells induced by monovalent anti-CD20 antibody].
    Liu YX; Fan DM; Xiong DS; Xu YF; Shao XF; Xu YS; Peng H; Yang M; Qin L; Zhu ZP; Yang CZ
    Ai Zheng; 2003 Dec; 22(12):1249-53. PubMed ID: 14693045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.
    Liu Y; Zheng M; Lai Z; Xiong D; Fan D; Xu Y; Peng H; Shao X; Xu Y; Yang M; Wang J; Liu H; Xie Y; Yang C; Zhu Z
    Cancer Lett; 2004 Mar; 205(2):143-53. PubMed ID: 15036646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
    Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
    Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20.
    Du J; Yang H; Guo Y; Ding J
    Mol Immunol; 2009 Jul; 46(11-12):2419-23. PubMed ID: 19427037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
    Cardoso RM; Zwick MB; Stanfield RL; Kunert R; Binley JM; Katinger H; Burton DR; Wilson IA
    Immunity; 2005 Feb; 22(2):163-73. PubMed ID: 15723805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma.
    Wu L; Wang C; Zhang D; Zhang X; Qian W; Zhao L; Wang H; Li B; Guo Y
    Cancer Lett; 2010 Jun; 292(2):208-14. PubMed ID: 20056316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition.
    Scheerer P; Kramer A; Otte L; Seifert M; Wessner H; Scholz C; Krauss N; Schneider-Mergener J; Höhne W
    J Mol Recognit; 2007; 20(4):263-74. PubMed ID: 17712773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo.
    Oscherwitz J; Gribbin TE; Cease KB
    Mol Immunol; 2010 Apr; 47(7-8):1484-91. PubMed ID: 20189250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.
    Kanyo ZF; Pan KM; Williamson RA; Burton DR; Prusiner SB; Fletterick RJ; Cohen FE
    J Mol Biol; 1999 Nov; 293(4):855-63. PubMed ID: 10543972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure at 1.95 A resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition.
    Dokurno P; Bates PA; Band HA; Stewart LM; Lally JM; Burchell JM; Taylor-Papadimitriou J; Snary D; Sternberg MJ; Freemont PS
    J Mol Biol; 1998 Dec; 284(3):713-28. PubMed ID: 9826510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.